(Q43038339)

12 November 2017

HIV seroconverting donors delay their return: screening test implications (English)

1 reference

12 November 2017

3

1 reference

12 November 2017

6

Michael P Busch

1 reference

12 November 2017

George B Schreiber

1

1 reference

12 November 2017

Simone A Glynn

2

1 reference

12 November 2017

Fanhui Kong

4

1 reference

12 November 2017

David Wright

5

1 reference

12 November 2017

Yongling Tu

7

1 reference

12 November 2017

Steven H Kleinman

8

1 reference

12 November 2017

Retrovirus Epidemiology Donor Study

9

1 reference

12 November 2017

1 April 2002

1 reference

12 November 2017

1 reference

12 November 2017

42

1 reference

12 November 2017

4

1 reference

12 November 2017

414-421

1 reference

Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors

12 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Characterization of the acute clinical illness associated with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Primary infection by type 1 human immunodeficiency virus: diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Epidemiology of hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Epidemiology of hepatitis C in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

Motivations to donate blood: demographic comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1438.2002.00084.X

10.1046/J.1525-1438.2002.00084.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference